Muhammed BEKÇİBAŞI, Muhammet ASENA, İhsan BAĞLI, Fatma BOZKURT, Ömer COŞKUN, Sevda YELEÇ

Evaluation of clinical and laboratory findings in severe group COVID-19 pregnants without comorbidity

Background/aim: COVID - 19 disease may be seen with different clinical presentations in pregnant women. Comorbid diseases are important factors affecting the progression of this disease. In this study, we aimed to evaluate the clinical and laboratory findings in pregnant women with COVID - 19 who had no comorbid disease. Material and methods: This retrospective designed study included 217 patients with Covid PCR positive in typically COVID - 19 clinic. The patients were classified into asymptomatic, nonsevere, and severe disease groups. The symptoms, laboratory results, hospital followups and intensive care records of the patients and the findings of new borns are presented. Results: Most of the patients (78%) were in the third trimester of pregnancy, and 103 patients in the study group had severe disease. Fever in the non-severe group and respiratory distress in the severe group were the most common symptoms in the patients. The severe clinical manifestations were specifically observed in the third trimester patients. In the severe group, neutrophil, lactat dehydrogenase, ferritin, CK - MB, IL – 6, and hospital stay were statistically higher than those in other groups (p < 0.05). Increase in BUN and creatine were the most predictive parameters in intensive care admission. While the intensive care unit (ICU) requirement was higher in patients in the severe group, premature birth was observed more frequently in the severe group (p < 0.05). Conclusion: COVID - 19 positive pregnant women were mostly detected in the third trimester, and the disease was more severe in this period. Also, the need for intensive care, the rate of delivery by caesarean section, and the rate of preterm delivery of these pregnant women were also found to be high.

PDF

___

1. Breslin N, Baptiste C, Gyamfi- Bannerman C, Miller R, Martinez R et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. American Journal of Obstetrics & Gynecology MFM 2020; 2 (2): 100118. doi: 10.1016/j.ajogmf.2020.100118
2. Berkowitz K, LaSala A. Risk factors associated with the increasing prevalence of pneumonia during pregnancy. American Journal of Obstetrics and Gynecology 1990; 163 (3): 981-985. doi: 10.1016/0002-9378(90)91109-p
3. Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID- 19 infection: a report of five cases. Translational Research 2020; 220: 1-13. doi: 10.1016/j.trsl.2020.04.007
4. Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerging Infectious Diseases 2006; 12 (11): 1638-1643. doi: 10.3201/eid1211.060152
5. Gardner MO, Doyle NM. Asthma in pregnancy. Obstetrics and Gynecology Clinics of North America 2004; 31 (2): 385-413. doi: 10.1016/j.ogc.2004.03.010
6. Dashraath P, Wong JLJ, Lim MXK, Lim LM , Li S et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. American Jounal of Obstetrics and Gynecology 2020; 222 (6): 521-531. doi: 10.1016/j.ajog.2020.03.021
7. Pierce- Williams RAM, Burd J, Felder L, Khoury R, Bernstein PS et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. American of Journal Obstetrics & Gynecology MFM 2020; 2 (3): 100134. doi: 10.1016/j.ajogmf.2020.100134
8. Wu X, Sun R, Chen J, Xie Y, Zhang S et al. Radiological findings and clinical characteristics of pregnant women with COVID- 19 pneumonia. International Journal of Gynecology & Obstetrics 2020; 150 (1): 58-63. doi: 10.1002/ijgo.13165
9. Gülsen A. Simple classification of COVID- 19 patients. Journal of Lung, Pulmonary & Respiratory Research 2020; 7 (3): 62-63. doi: 10.15406/jlprr:2020.07.00230
10. Yan J, Guo J, Fan C, Juan J, Yu X et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. American Journal of Obstetrircs and Gynecology 2020; 223 (1): 111.e1- 111.e14. doi: 10.1016/j.ajog.2020.04.014
11. Delahoy MJ, Whitaker M, O’Halloran A, Chai SJ, Kirley PD et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID- 19- COVID- NET, 13 States, March 1- August 22, 2020. MMWR-Morbidity and Mortality Weekly Report 2020; 69 (38): 1347-1354. doi: 10.15585/mmwr.mm6938e1
12. Mohr- Sasson A, Chayo J, Bart Y, Meyer R, Sivan E et al. Laboratory characteristics of pregnant compared to nonpregnant women infected with SARS- CoV- 2. Archives of Gynecology and Obstetrics 2020; 302 (3): 629-634. doi: 10.1007/s00404-020-05655-7
13. Ghayda RA, Lee J, Lee JY, Kim DK, Lee KH et al. Correlations of clinical and laboratory characteristics of COVID- 19: a systematic review and meta- analysis. International Journal of Environmental Research and Public Health 2020; 17 (14): 5026. doi: 10.3390/ijerph17145026
14. Suleyman G, Fadel RA, Malette KM, Hammond C, Hafsa Abdulla H et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in Metropolitan Detroit. JAMA Network Open 2020; 3 (6): e2012270. doi: 10.1001/jamanetworkopen.2020.12270
15. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China. The Journal of the American Medical Association 2020; 323 (11): 1061- 1069. doi: 10.1001/jama.2020.1585
16. Fang XW, Mei Q, Yang TJ, Zhang L, Yang Y et al. Clinical characteristics and treatment strategies of 79 patients with COVID-19 . Chinese Pharmacological Bulletin 2020; 36 (4). (in Chinese). doi: 10.3969/j.issn.1001-1978.2020.04.002
17. Tianxin X, Jiaming L, Fei X, Na C, Yang L et al. Analysis of clinical characteristics of 49 patients with novel coronavirus pneumonia in Jiangxi. Chinese Journal of Respiratory and Critical Care 2020; 19 (2): 154-160. (in Chinese). doi: 10.7507/1671-6205.202002070
18. Cao Y, Chen H, Guo J, Yu X, Wen X et al. Maternal and neonatal outcomes in pregnant women with COVID-19: a systemic review. Chinese Journal of Perinatal Medicine 2020; 23 (7): 447-455. (in Chinese). doı: 10.3760/ cma.j.cn113903-20200402-00298
19. Scott R, Hewitt H, Mallet C, Herd L, Shibley C et al. Recognition and treatment of severe COVID-19 in Pregnancy: Lessons from a cohort of 69 infected women and an evidence- based guideline. Authorea 2020. doi: 10. 22541/ au.160616173.35255142/v1.
20. Andrikopoulou M, Madden N, Wen T, Aubey JJ, Aziz A et al. Symptoms and critical illness among obstetric patients with coronavirus Disease 2019 (COVID- 19) infection. Obstetrics and Gynecology 2020; 136 (2): 291-299. doi: 10.1097/ AOG.0000000000003996
21. Kayema G, Lecarpentierl E, Deruellef P, Bretellec F, Azriab E et al. A snapshot of the COVID- 19 pandemic among pregnant women in France. Journal of Gynecology Obstetrics and Human Reproduction 2020; 49 (7): 101826. doi: 10.1016/j. jogoh.2020.101826
22. Saccone G, Sen C, Mascio DD, Galindo A, Grünebaum A et al. Maternal and perinatal outcomes of pregnant women with SARS- CoV- 2 infection. Ultrasound In Obstetrıcs & Gynecology 2021; 57 (2): 232–241. doı: 10.1002/uog.23107
23. Chen H, Guo J, Wang C, Luo F, Yu X et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809–815. doi: 10.1016/S0140-6736(20)30360-3
24. Knight M, Bunch K, Vousden N, Morris E, Simpson N et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS- CoV- 2 infection in UK: national population based cohort study. BMJ- British Medical Journal 2020; 369: m2107. doi: 10.1136/bmj.m2107
25. Vojtek I, Dieussaert I, Doherty TM, Franck V, Hanssens L et al. Maternal immunization: where are we now and how to move forward? Annals of Medicine 2018; 50 (3): 193-208. doi: 10.1080/07853890.2017.1421320